ADVB

Peers: BIAF PRPO MDXH BNR IMDX QTRX XGN BNGO CODX LUCD

Index	-
Market Cap	3.64M
Enterprise Value	3.66M
Income	-0.24M
Sales	0.00M
Book/sh	0.23
Cash/sh	0.01
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	12
IPO	Mar 06, 2025

P/E	-
Forward P/E	-
PEG	-
P/S	-
P/B	9.43
P/C	363.66
P/FCF	-
EV/EBITDA	-
EV/Sales	-
Quick Ratio	9.33
Current Ratio	9.33
Debt/Eq	0.08
LT Debt/Eq	0.00
Option/Short	No / Yes

EPS (ttm)	-0.08
EPS next Y	-
EPS next Q	-
EPS this Y	-
EPS next Y	-
EPS next 5Y	-
EPS past 3/5Y	-18.91% -25.94%
Sales past 3/5Y	- -
EPS Y/Y TTM	14.35%
Sales Y/Y TTM	-
EPS Q/Q	-1139.52%
Sales Q/Q	-
Earnings	-
EPS/Sales Surpr.	- -

Insider Own	42.70%
Insider Trans	0.00%
Inst Own	0.06%
Inst Trans	153.34%
ROA	-60.71%
ROE	-78.78%
ROIC	-61.60%
Gross Margin	-110.23%
Oper. Margin	-5535.26%
Profit Margin	-5880.80%
SMA20	-43.87%
SMA50	-64.96%
SMA200	-62.60%
Trades

Shs Outstand	1.65M
Shs Float	0.95M
Short Float	1.03%
Short Ratio	0.08
Short Interest	0.01M
52W High	24.23 -90.92%
52W Low	2.04 7.84%
Volatility	18.46% 14.99%
ATR (14)	0.56
RSI (14)	21.79
Beta	0.67
Rel Volume	0.08
Avg Volume	116.53K
Volume	2,402

Perf Week	-27.63%
Perf Month	-65.30%
Perf Quarter	-72.29%
Perf Half Y	-67.93%
Perf YTD	-62.30%
Perf Year	-76.10%
Perf 3Y	-
Perf 5Y	-
Perf 10Y	-
Recom	-
Target Price	-
Prev Close	2.08
Price	2.20
Change %	6.02%

Feb-18-26 07:00AM	Advanced Biomed Inc. Announces 1 for 20 Share Consolidation (GlobeNewswire) -10.69%
Feb-13-26 08:00AM	Advanced Biomed Inc. Announces 120-Case Feasibility Study with Chi-Mei Medical Center to Validate A+PerfusC - Integrated Perfusion 3D Cell Culture Platform for Precision Medicine and Drug Discovery (GlobeNewswire)
Dec-31-25 10:25AM	Advanced Biomed sells Hong Kong subsidiary for $23,000 (TipRanks) -13.82%
Dec-30-25 10:17AM	Advanced Biomed Inc. Announces Disposal of its Hong Kong Subsidiary (GlobeNewswire)
Sep-19-25 08:30AM	Advanced Biomed Inc. Announces Launch of A+PerfusC - Integrated Perfusion 3D Cell Culture Platform for Precision Medicine and Drug Discovery (GlobeNewswire) -17.18%
12:29PM	Loading…
Mar-07-25 12:29PM	Advanced Biomed Inc. Announces Closing Of US$6.56 Million Initial Public Offering (GlobeNewswire)
Mar-06-25 09:02AM	Advanced Biomed Inc. Announces Pricing of Initial Public Offering (GlobeNewswire)

Advanced Biomed, Inc. operates as a holding company with interests in developing biochip technologies. It engages in the research & development of microfluidic biochip technologies and provides tumor diagnosis and treatment technology applications. The company was founded by Yi Lu and Steven I-Fang Cheng in 2014 and is headquartered in Tainan, Taiwan.

CFO & DirectorMr. Mingze Yin

CEO & ChairmanMr. Xiaomin Chen Ph.D.

Director of Investor Relations- Alan

SecretaryDr. Hung To Pau Ph.D.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

Advanced Biomed Inc

Upgrade your Finviz experience